Clinical Trial

Propolis for Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the efficacy of propolis in the prevention of oral mucositis and reducing pain score in children undergoing chemotherapy, and assessing its impact on body mass index, pediatric quality of life and total antioxidant assay. The main question it aims to answer is: What is the effect of propolis on oral mucositis scores in children undergoing chemotherapy? Participants will: Take propolis 3 times daily for 21 days follow up weekly for 3 weeks
Trial Details
NCT Number NCT07073092
Lead Sponsor Ain Shams University
Conditions Oral Mucositis Due to Chemotherapy
Enrollment 50 participants
Start Date 2025-07-15
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-18